Search research articles
Contact Us
Filters
Showing results (151-160 of 354) with videos related to
Page
of 36
Sort By:
Plos One
|
March 1, 2007
Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays
Rani E George, Edward F Attiyeh, Shuli Li, et al.
British Journal of Haematology
|
June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma
Jonathan W Friedberg, Donna Neuberg, John G Gribben, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2023
Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors
Sirui Ma, Rushad Patell, Eric Miller, et al.
Blood
|
October 24, 2002
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation
Joseph H Antin, Daniel Weisdorf, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2013
Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia
Vincent Gagné, Julie Rousseau, Malgorzata Labuda, et al.
Blood Advances
|
August 22, 2022
Absolute neutrophil count by Duffy status among healthy Black and African American adults
Lauren E Merz, Charlotte M Story, Miriam A Osei, et al.
Leukemia & Lymphoma
|
April 23, 2004
Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma
Jennifer R Brown, Guylaine Gaudet, Jonathan W Friedberg, et al.
Cancer Research
|
January 28, 2010
Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells
Melinda A Biernacki, Ovidiu Marina, Wandi Zhang, et al.
Journal of Pediatric Hematology/Oncology
|
November 12, 2005
A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer
Mark W Kieran, Christopher D Turner, Joshua B Rubin, et al.
Cell
|
November 20, 2015
Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes
Leng-Siew Yeap, Joyce K Hwang, Zhou Du, et al.
Page
of 36
Search research articles
Search
Showing results (151-160 of 354) with videos related to
Sort By:
Page
of 36
Plos One
|
March 1, 2007
Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays
Rani E George, Edward F Attiyeh, Shuli Li, et al.
British Journal of Haematology
|
June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma
Jonathan W Friedberg, Donna Neuberg, John G Gribben, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2023
Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors
Sirui Ma, Rushad Patell, Eric Miller, et al.
Blood
|
October 24, 2002
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation
Joseph H Antin, Daniel Weisdorf, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2013
Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia
Vincent Gagné, Julie Rousseau, Malgorzata Labuda, et al.
Blood Advances
|
August 22, 2022
Absolute neutrophil count by Duffy status among healthy Black and African American adults
Lauren E Merz, Charlotte M Story, Miriam A Osei, et al.
Leukemia & Lymphoma
|
April 23, 2004
Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma
Jennifer R Brown, Guylaine Gaudet, Jonathan W Friedberg, et al.
Cancer Research
|
January 28, 2010
Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells
Melinda A Biernacki, Ovidiu Marina, Wandi Zhang, et al.
Journal of Pediatric Hematology/Oncology
|
November 12, 2005
A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer
Mark W Kieran, Christopher D Turner, Joshua B Rubin, et al.
Cell
|
November 20, 2015
Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes
Leng-Siew Yeap, Joyce K Hwang, Zhou Du, et al.
Page
of 36